141 related articles for article (PubMed ID: 683130)
41. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
Diggs CH; Wiernik PH; Smyth AC
Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
[No Abstract] [Full Text] [Related]
42. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
[TBL] [Abstract][Full Text] [Related]
43. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
Trux F
Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
[No Abstract] [Full Text] [Related]
44. Phase I trial of ftorafur combined with mitomycin C or methyl-CCNU in gastrointestinal cancers.
Buroker T; Baker L; Correa J; Schwartz LA; Vailtkevicius VK
Cancer Treat Rep; 1977; 61(3):463-7. PubMed ID: 326403
[TBL] [Abstract][Full Text] [Related]
45. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
[TBL] [Abstract][Full Text] [Related]
46. The gasteointestinal oncology clinic. A multidisciplinary approach to cancer diagnosis and management at a University Medical Center.
Levin B; Karlin DA; Schulman S; Thorp GW; Kirsner JB; Rosenberg IH
Surg Clin North Am; 1976 Feb; 56(1):233. PubMed ID: 1251304
[No Abstract] [Full Text] [Related]
47. Chemotherapy of colorectal carcinoma.
Woolley PV; Macdonald JS; Schein PS
Semin Oncol; 1976 Dec; 3(4):415-20. PubMed ID: 136751
[No Abstract] [Full Text] [Related]
48. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
49. Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancer.
Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
Cancer Chemother Rep; 1972 Aug; 56(4):551-2. PubMed ID: 4263582
[No Abstract] [Full Text] [Related]
50. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
51. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
Moertel CG; Douglass HO; Hanley J; Carbone PP
Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
[No Abstract] [Full Text] [Related]
52. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
Joss RA; Goldberg RS; Yates JW
Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
[TBL] [Abstract][Full Text] [Related]
53. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
[TBL] [Abstract][Full Text] [Related]
54. Current protocol approaches in large bowel cancer.
Carter SK
Semin Oncol; 1976 Dec; 3(4):433-43. PubMed ID: 793018
[No Abstract] [Full Text] [Related]
55. FIVB--a new combination of drugs in the treatment of cancer.
Van Eden EB; Falkson G; Van der Merwe AM; Van Dyk JJ; Falkson HC
S Afr Med J; 1973 Jun; 47(23):982-4. PubMed ID: 4714282
[No Abstract] [Full Text] [Related]
56. Adjuvant chemotherapy of colorectal carcinoma.
Ahmann FR
Ariz Med; 1982 Aug; 39(8):524-5. PubMed ID: 6814403
[No Abstract] [Full Text] [Related]
57. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
[TBL] [Abstract][Full Text] [Related]
58. The combination of methyl-CCNU and irradiation: cell survival studies on a human tumor xenograft.
Bateman AE; Fu KK; Towse GD
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1545-8. PubMed ID: 536260
[No Abstract] [Full Text] [Related]
59. The West Midlands gastric carcinoma chemotherapy trial: planning and results.
Kingston RD; Ellis DJ; Powell J; Brookes VS; Waterhouse JA; Hurst MD; Smith JA
Clin Oncol; 1978 Mar; 4(1):55-69. PubMed ID: 346275
[No Abstract] [Full Text] [Related]
60. Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases.
Lehane DE; Lane M; Tranum B; Costanzi J; Padilla F
Cancer Treat Rep; 1977 Aug; 61(5):889-91. PubMed ID: 329982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
